Aecon (ARE) ran another 7% on a Q3 beat, anchored by nuclear revenue which rose ~$150M Y/Y and is showing no signs of slowing down.

Between the print, its recent nuclear contract win, and Brookfield & Cameco’s $80B nuclear partnership with the U.S. government… Aecon is up 30% in the past week and trades near peak valuation.

Disclaimer: Content on this site, including research reports, is provided by Bullpen Finance Inc. for informational purposes only and does not constitute investment advice. Bullpen Finance Inc. receives compensation from issuers for research coverage; such compensation does not influence opinions expressed. For complete disclosures, please see our Legal & Disclosures section.